DiaCarta Launches OTC at Home Fecal Occult Blood Test to Complement its ColoScape™ Test

/PRNewswire/ -- DiaCarta, Inc., a leading innovator in precision medicine diagnostic biomarker assays, announced today that DiaCarta received US FDA 510(k)...

Related Keywords

California ,United States ,Ramanathan Ram Vairavan ,Adam Aiguo Zhang ,Prnewswire Diacarta Inc ,Diacarta Inc ,Colon Fecal Occult Blood Test ,Fecal Occult Blood Test ,Xeno Nucleic Acid ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Medical Equipment ,Biotechnology ,Otc ,Mallcap ,New Products Amp Services ,